C Mangurian , E Goss , J Newcomer 
 

Abstract

Hispanics with severe mental illness have a higher prevalence of metabolic syndrome than persons with schizophrenia in general or Hispanics in the general population, which suggests additive risk (1,2). Despite national guideline recommendations, metabolic screening and treatment rates are low among persons with severe mental illness (3). Little is known about rates among Hispanics in this population. We determined screening and treatment rates for metabolic abnormalities in an urban sample of predominantly Hispanic inpatients with severe mental illness. We hypothesized that we would find low rates and that these inpatients would prefer pharmacological treatments over behavioral interventions for metabolic abnormalities.

To access full article, click here.